Ultomiris Drug Interactions
Currently displaying a list of 89 drugs known to interact with Ultomiris (ravulizumab).
- 31 major drug interactions
- 49 moderate drug interactions
- 9 minor drug interactions
Medications known to interact with Ultomiris
Note: Showing generic names only.
A
- abrocitinib
- adalimumab
- alefacept
- alemtuzumab
- allogeneic processed thymus tissue
- anakinra
- anifrolumab
- ashwaganda
- atezolizumab
- avelumab
- azathioprine
B
C
D
- denosumab
- deucravacitinib
- deuruxolitinib
- dimethyl fumarate
- diroximel fumarate
- dostarlimab
- durvalumab
E
F
G
I
- immune globulin intravenous
- immune globulin intravenous and subcutaneous
- infliximab
- ipilimumab
- iptacopan
L
- lactobacillus acidophilus
- lactobacillus reuteri
- lactobacillus rhamnosus
- lactobacillus rhamnosus gg
- leflunomide
- loncastuximab tesirine
M
N
O
P
R
S
T
- tacrolimus topical
- talimogene laherparepvec
- teriflunomide
- tislelizumab
- tofacitinib
- toripalimab
- tremelimumab
U
V
Z
Ultomiris disease interactions
There are 3 disease interactions with Ultomiris (ravulizumab) which include:
Report options
QR code containing a link to this page
More about Ultomiris (ravulizumab)
- Ultomiris consumer information
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (8)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: selective immunosuppressants
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
